跳至主要内容
临床试验/CTRI/2025/06/088741
CTRI/2025/06/088741尚未招募4 期

Comparative evaluation of diagnostic and prognostic accuracy of Procalcitonin, CD64, Group II phospholipase A 2 and Human neutrophil lipocalin for adult sepsis and septic shock patients admitted in Emergency Department.

Sanjay Gandhi Post Graduate Institute1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2025年6月24日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
118
试验地点
1
主要终点
The diagnostic accuracy of CD64, PLA 2GIIA, HML and Procalcitonin in sepsis and septic shock patients in emergency department.

研究概览

简要总结

Project summary-

Thoughit’s well known that timely identification of septic shock is decisive toimprove any septic patient’s mortality, no biomarker is still existing todetect it in the initiation. Procalcitonin, CD64,Group II phospholipaseA 2, and Human neutrophil lipocalin are the promising one among 260 tested biomarkers.In our study, we want to compare the diagnostic accuracy of these biomarkers inseptic shock patients in our emergency department. Additionally, prognosticguidance if any will be seen.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1 Age more than 18 years
  • sepsis according to sepsis 3 criteria.
  • 3, emergency department.

排除标准

  • Not giving consent for test.
  • Patients with immune-related diseases- can influence biomarker level.

结局指标

主要结局

The diagnostic accuracy of CD64, PLA 2GIIA, HML and Procalcitonin in sepsis and septic shock patients in emergency department.

时间窗: 1 year

次要结局

  • any correlation between mortality with admission biomarker levels & admission SOFA score.(1 year)

研究者

发起方
Sanjay Gandhi Post Graduate Institute
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验